Tables S3 and S4, a low expression level of RNF43 predicted advanced TNM stage, a higher WHO/ISUP grade and SSIGN score, and a worse OS and PFS in ccRCC patients in the training and validation cohorts (Suppl. Here, RNF43 is linked to nonpapillary renal cell carcinoma.